NP48925c Hereditary Angioedema Branded Medicines (Ruconest)
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-04fd8d32014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
04 Apr 2025
Description
Supply of conestat alfa 2,100unit powder for solution for injection vials (Ruconest®) to NHS Scotland:
Scope
- Reference
- ocds-h6vhtk-04fd8d
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Negotiated without publication of a contract notice
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
Awarded suppliers· 1 supplier
Awarded —
Award value
—
Other contracts from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Pharming Group· 4
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| NP48925c Hereditary Angioedema Branded Medicines (Ruconest) | contract | — | 02 May 2025 |
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 | contract | — | 22 Apr 2025 |
| Human Derived Blood Products | contract | — | 28 Aug 2024 |
| NHS National Framework Agreement for the Supply of products for the management of Hereditary Angioedema | contract | — | 19 Jul 2022 |